PETER G TRABER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PETER G TRABER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER G TRABER. PETER G TRABER is Director in Caladrius Biosciences, Inc. ($NBS) and Director in TANOX INC ($TNOX) and President & CEO in GALECTIN THERAPEUTICS INC ($GALT) and Chief Medical Officer in SELECTA BIOSCIENCES INC ($SELB).
Latest Insider Trading Transactions of PETER G TRABER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, NBS, GALT, SELB, TNOX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2021 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Buy | P | 3.99 | 20,000 | 79,850 | 135,500 | 115.5 K to 135.5 K (+17.32 %) |
| Mar 19 2021 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Buy | P | 4.50 | 10,000 | 45,000 | 98,000 | 88 K to 98 K (+11.36 %) |
| Mar 19 2021 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Buy | P | 4.53 | 10,000 | 45,295 | 88,000 | 78 K to 88 K (+12.82 %) |
| Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | TRABER PETER G | Director | Grant | A | 0.00 | 37,735 | 0 | 83,760 | 46 K to 83.8 K (+81.99 %) |
| Jan 06 2021 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Option Exercise | A | 2.99 | 230,000 | 687,700 | 230,000 | |
| Jan 06 2021 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Grant | A | 0.00 | 38,000 | 0 | 78,000 | 40 K to 78 K (+95.00 %) |
| Jan 06 2021 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Option Exercise | A | 2.99 | 230,000 | 687,700 | 230,000 | |
| Jan 06 2021 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Grant | A | 0.00 | 38,000 | 0 | 78,000 | 40 K to 78 K (+95.00 %) |
| Dec 16 2020 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Buy | P | 3.24 | 40,000 | 129,424 | 40,000 | 0 to 40 K |
| Aug 04 2020 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Option Exercise | A | 2.38 | 650,000 | 1,547,000 | 650,000 | |
| Jan 14 2020 | NBS | CALADRIUS BIOSCIEN ... | TRABER PETER G | Director | Grant | A | 3.28 | 18,292 | 59,998 | 46,025 | 27.7 K to 46 K (+65.96 %) |
| Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | TRABER PETER G | Director | Grant | A | 4.95 | 12,121 | 59,999 | 27,733 | 15.6 K to 27.7 K (+77.64 %) |
| Jan 10 2019 | NBS | CALADRIUS BIOSCIEN ... | TRABER PETER G | Director | Grant | A | 0.00 | 8,747 | 0 | 15,612 | 6.9 K to 15.6 K (+127.41 %) |
| Jun 15 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Option Exercise | M | 0.87 | 100,000 | 87,000 | 50,000 | |
| Jun 15 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Sell | S | 7.51 | 100,000 | 751,000 | 107,333 | 207.3 K to 107.3 K (-48.23 %) |
| Jun 15 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Buy | M | 0.87 | 100,000 | 87,000 | 207,333 | 107.3 K to 207.3 K (+93.17 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Option Exercise | M | 0.87 | 70,000 | 60,900 | 150,000 | |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Sell | S | 5.86 | 70,000 | 409,997 | 107,333 | 177.3 K to 107.3 K (-39.47 %) |
| Jun 12 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Buy | M | 0.87 | 70,000 | 60,900 | 177,333 | 107.3 K to 177.3 K (+65.22 %) |
| May 24 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Option Exercise | A | 4.16 | 125,000 | 520,000 | 125,000 | |
| Jan 17 2018 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Option Exercise | A | 5.87 | 125,000 | 733,750 | 125,000 | |
| Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | TRABER PETER G | Director | Option Exercise | A | 0.00 | 8,747 | 0 | 8,747 | |
| May 18 2017 | NBS | Caladrius Bioscien ... | TRABER PETER G | Director | Grant | A | 0.00 | 2,565 | 0 | 6,865 | 4.3 K to 6.9 K (+59.65 %) |
| Jan 31 2017 | NBS | Caladrius Bioscien ... | TRABER PETER G | Director | Option Exercise | A | 3.54 | 2,750 | 9,735 | 2,750 | |
| Jan 31 2017 | NBS | Caladrius Bioscien ... | TRABER PETER G | Director | Grant | A | 0.00 | 1,650 | 0 | 4,300 | 2.7 K to 4.3 K (+62.26 %) |
| Dec 06 2016 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Option Exercise | A | 0.87 | 220,000 | 191,400 | 220,000 | |
| Jun 23 2016 | NBS | Caladrius Bioscien ... | TRABER PETER G | Director | Option Exercise | A | 0.52 | 12,500 | 6,450 | 12,500 | |
| Jun 23 2016 | NBS | Caladrius Bioscien ... | TRABER PETER G | Director | Grant | A | 0.00 | 7,500 | 0 | 26,500 | 19 K to 26.5 K (+39.47 %) |
| Jan 27 2016 | NBS | Caladrius Bioscien ... | TRABER PETER G | Director | Option Exercise | A | 0.63 | 15,000 | 9,450 | 15,000 | |
| Jan 27 2016 | NBS | Caladrius Bioscien ... | TRABER PETER G | Director | Grant | A | 0.00 | 9,000 | 0 | 19,000 | 10 K to 19 K (+90.00 %) |
| Jan 22 2016 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Option Exercise | A | 1.37 | 134,000 | 183,580 | 134,000 | |
| Aug 12 2015 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Buy | P | 2.00 | 2,000 | 4,000 | 107,333 | 105.3 K to 107.3 K (+1.90 %) |
| Jun 04 2015 | NBS | Caladrius Bioscien ... | TRABER PETER G | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Jun 01 2015 | GALT | GALECTIN THERAPEUT ... | TRABER PETER G | President & CEO | Buy | P | 2.53 | 4,000 | 10,120 | 105,333 | 101.3 K to 105.3 K (+3.95 %) |
| Jun 06 2006 | TNOX | TANOX INC | TRABER PETER G | Director | Option Exercise | A | 14.47 | 10,000 | 144,700 | 10,000 | |
| Jun 14 2005 | TNOX | TANOX INC | TRABER PETER G | Director | Option Exercise | A | 9.87 | 10,000 | 98,700 | 10,000 | |
| Mar 23 2004 | TNOX | TANOX INC | TRABER PETER G | Director | Option Exercise | A | 14.89 | 20,000 | 297,800 | 20,000 | |
| Mar 23 2004 | TNOX | TANOX INC | TRABER PETER G | Director | Option Exercise | A | 14.89 | 20,000 | 297,800 | 20,000 |
Page: 1